Nature Communications (Sep 2023)

A chemical catalyst enabling histone acylation with endogenous acyl-CoA

  • Misuzu Habazaki,
  • Shinsuke Mizumoto,
  • Hidetoshi Kajino,
  • Tomoya Kujirai,
  • Hitoshi Kurumizaka,
  • Shigehiro A. Kawashima,
  • Kenzo Yamatsugu,
  • Motomu Kanai

DOI
https://doi.org/10.1038/s41467-023-41426-z
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 12

Abstract

Read online

Abstract Life emerges from a network of biomolecules and chemical reactions catalyzed by enzymes. As enzyme abnormalities are often connected to various diseases, a chemical catalyst promoting physiologically important intracellular reactions in place of malfunctional endogenous enzymes would have great utility in understanding and treating diseases. However, research into such small-molecule chemical enzyme surrogates remains limited, due to difficulties in developing a reactive catalyst capable of activating inert cellular metabolites present at low concentrations. Herein, we report a small-molecule catalyst, mBnA, as a surrogate for a histone acetyltransferase. A hydroxamic acid moiety of suitable electronic characteristics at the catalytic site, paired with a thiol-thioester exchange process, enables mBnA to activate endogenous acyl-CoAs present in low concentrations and promote histone lysine acylations in living cells without the addition of exogenous acyl donors. An enzyme surrogate utilizing cellular metabolites will be a unique tool for elucidation of and synthetic intervention in the chemistry of life and disease.